LIANNE MCGINN BUNN: Open Payments
NPI 1568779882 · ALLENTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,161 in 96 payments from 17 companies in 2025. Trend: 2023 $1,621 · 2024 $2,037 · 2025 $2,161
Food & beverage: $1,998Education: $163
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 33 | $628 |
| Galderma Laboratories, L.P. | 8 | $368 |
| ABBVIE INC. | 15 | $204 |
| Regeneron Healthcare Solutions, Inc. | 6 | $140 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $117 |
| Lilly USA, LLC | 6 | $105 |
| UCB, Inc. | 4 | $103 |
| Amgen Inc. | 5 | $101 |
| Novartis Pharmaceuticals Corporation | 3 | $73 |
| Botanix SB Inc | 2 | $57 |
Products named: TREMFYA, NEMLUVIO, SKYRIZI, DUPIXENT, Bimzelx, Otezla, TALTZ, COSENTYX.
Industry payments across PA — which companies pay providers there.
